Physician profile
Bjorn Thorarinsson
NPI 1932206141
$3,632.39
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,782 · 2020: $640 · 2021: $617 · 2022: $237 · 2023: $293 · 2024: $63.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $799.96 | 2019-2023 | Uptravi |
| Glaxosmithkline, LLC. | $714.69 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $577.32 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $316.87 | 2019-2021 | |
| Genentech USA, INC. | $257.76 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $167.74 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $114.35 | 2019-2021 | |
| United Therapeutics Corporation | $104.23 | 2021 | |
| Pulmonx Corporation | $95.12 | 2019-2020 | |
| Electromed, INC. | $81.48 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $73.63 | 2019-2020 | |
| Grifols USA, LLC | $46.81 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $44.83 | 2019 | |
| Mylan Specialty L.P. | $35.94 | 2019-2020 | |
| Medical Graphics Corporation | $34.38 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $29.31 | 2019 | |
| Circassia INC. | $23.90 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.09 | 2019 | |
| Genzyme Corporation | $18.26 | 2021 | |
| Apria Healthcare LLC | $16.39 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $15.93 | 2020 | |
| Allergan, INC. | $15.66 | 2019 | |
| Gilead Sciences, INC. | $14.80 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bjorn Thorarinsson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.